May 30, 2023 / 12:30PM GMT
Tyler Van Buren - TD Cowen - Analyst
Good morning, everyone. Welcome back. I hope you had a great weekend. Tyler Van Buren here, senior biotech analyst at TD Cowen. We'd like to welcome everyone to our 4th Annual Oncology Innovation Summit. For our first session of the day, we have a fireside chat with Deciphera. And it's my pleasure to introduce Steve Hoerter, the President and CEO; and Matt Sherman, the Chief Medical Officer.
Steve and Matt, it's a privilege to have you here. Thank you very much for joining me.
Steve Hoerter - Deciphera Pharmaceuticals, Inc. - President & CEO
Yeah. Thanks, Tyler.
Matt Sherman - Deciphera Pharmaceuticals, Inc. - EVP & Chief Medical Officer
Thanks, Tyler.
Steve Hoerter - Deciphera Pharmaceuticals, Inc. - President & CEO
We're pleased to be here.
Tyler Van Buren - TD Cowen - Analyst
(Conference Instructions). We'll do our best to get it asked in the 25-minute fireside chat
Deciphera Pharmaceuticals Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
